| Income Statement |
| Total Revenue | 239.00K |
|
| Revenues (USD) | 239.00K |
| Cost of Revenue | 82.00K |
| Gross Profit | 157.00K |
| Operating Expenses | 11.56M |
| Research and Development Expense | 4.49M |
| Selling, General and Administrative Expense | 4.79M |
| Operating Income | -11.40M |
| Interest Expense | 20.00K |
| Net Income | -11.26M |
| Net Income Common Stock | -11.26M |
| Net Income Common Stock (USD) | -11.26M |
| Consolidated Income | -11.26M |
| Earnings per Basic Share | -0.31 |
| Earnings per Basic Share (USD) | -0.31 |
| Earnings per Diluted Share | -0.31 |
| Earning Before Interest & Taxes (EBIT) | -11.24M |
| Earning Before Interest & Taxes (USD) | -11.24M |
| Weighted Average Shares | 36.75M |
| Weighted Average Shares Diluted | 36.75M |
| Balance Sheet |
| Cash and Equivalents | 18.49M |
| Cash and Equivalents (USD) | 18.49M |
| Trade and Non-Trade Receivables | 192.00K |
| Current Assets | 20.54M |
| Property, Plant & Equipment Net | 8.10M |
| Total Assets | 29.44M |
| Debt Current | 1.71M |
| Total Debt | 2.63M |
| Current Liabilities | 10.29M |
| Debt Non-Current | 915.00K |
| Total Liabilities | 50.74M |
| Accumulated Retained Earnings (Deficit) | -416.31M |
| Accumulated Other Comprehensive Income | 67.00K |
| Shareholders Equity | -21.30M |
| Shareholders Equity (USD) | -21.30M |
| Assets Non-Current | 8.90M |
| Total Debt (USD) | 2.63M |
| Inventory | 207.00K |
| Liabilities Non-Current | 40.46M |
| Trade and Non-Trade Payables | 3.85M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 665.00K |
| Net Cash Flow from Financing | -564.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.63M |
| Capital Expenditure | -779.00K |
| Issuance (Purchase) of Equity Shares | 10.00K |
| Issuance (Repayment) of Debt Securities | -152.00K |
| Net Cash Flow from Investing | -779.00K |
| Net Cash Flow from Operations | -9.27M |
| Effect of Exchange Rate Changes on Cash | -16.00K |
| Share Based Compensation | 669.00K |